The Massachusetts Department of Public Health and state attorney general approved the merger under conditions, including limited annual price increases over the next seven years, maintaining $71.6 million in commitments to support healthcare services for low-income and underserved communities statewide, and good faith efforts to enroll all licensed providers in MassHealth — the state’s Medicaid and children’s health insurance program — within three years.
Maura Healey, attorney general of Massachusetts, is negotiating with Beth Israel Lahey to appoint an independent monitor to track adherence to these conditions.
“In five years time, if patients and their families tell us that we have made a difference in their lives, then we will have been wildly successful as far as I’m concerned,” said Kevin Tabb, MD, president and CEO of Beth Israel Lahey Health.
More articles on healthcare transactions:
Littleton Regional Healthcare drops New Hampshire consortium affiliation
Healthy Connections to buy Arkansas hospital
Mayo Clinic adds Mexico hospital to care network
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
